- cafead   Aug 08, 2022 at 11:32: PM
via After months of delay in its decision, the FDA has given a green light to Pfizer and Myovant’s drug Myfembree for pain related endometriosis, a gynecological condition associated with moderate to severe pain, making it the drug’s second indication approval.
article source
article source